Carpal Tunnel Syndrome(CTS). Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: Intervention group: In the first group, the combination of topical injection of triamcinolone and lidocaine is injected twice in two weeks, each time 2 cc of drug including 1 cc of tri
Sponsors
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with a final diagnosis of moderate carpal tunnel syndrome with pain or paresthesia No history of steroid injection into the carpal tunnel No history of carpal tunnel surgery Absence of underlying diseases
Exclusion criteria
Exclusion criteria: Patients with severe carpal tunnel syndrome Severe hand dysfunction that requires surgical release of the median nerve Patients with neuropathy Upper limb fractures Burns in the upper limbs Patients undergoing hand surgery Patients with allergies to steroids, vitamin B6 and lidocaine Patients who do not have the necessary cooperation to follow up after the injection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms of patients (anesthesia). Timepoint: Before treatment, three weeks and three months after treatment. Method of measurement: Using the Visual Analogue Scale ruler.;Clinical symptoms of patients (paresthesia). Timepoint: Before treatment, three weeks and three months after treatment. Method of measurement: Using the Visual Analogue Scale ruler.;Clinical symptoms of patients (pain). Timepoint: Before treatment, three weeks and three months after treatment. Method of measurement: Using the Visual Analogue Scale ruler.;Electrodiagnostics. Timepoint: Before treatment, three weeks and three months after treatment. Method of measurement: Nerve Conduction Velocity. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMeysam Ehsani
Bagheiat-allah University of Medical Sciences
Outcome results
None listed